Formula Center ItaliaRESEARCH · DEVELOPMENT · HUMAN TELEMETRY
ITEN
HUMETRY MED / FROM CLINICAL EXPERIENCE TO THE NEW GENERATION

From the track to care.
A new human horizon.

Technology created for motorsport meets healthcare during the Covid-19 emergency. The experience of 2020–2021 is today a concrete basis for the path towards the new medical generation.

Illustrative scenario: Humetry MED white applied directly to the skin of the chest in a doctor's office
Future scenario concept · does not represent study patients or a final product
First HumetryMED configuration with chest strap, arm and wrist supports
First HumetryMED configuration · archive photograph
THE EARLIER DEVICE

Technology changes
the way it is worn.

A photograph of the first configurations makes the transition from the driver's shirt to the healthcare context concrete: chest strap and wearable supports.

During testing, the experience of use guides further evolutions, up to configurations with the unit attached to the belt and chest sensors on adhesive supports.

Videos of the medical phase ↗
THE CLINICAL PATH / 2020–2021

An emergency.
A new application.

FCI recognizes the possibility of adapting the system to remote monitoring and puts the work developed in motorsport at the service of a new context.

2020 / ADAPTATION

From the shirt to the first bands

The system is rethought in terms of wearability: from the technical driver shirt to configurations with chest strap and sensors on the wrist. Comparison with clinical use will bring further ergonomic evolutions.

JULY–SEPTEMBER 2020

The study at the Policlinico Tor Vergata

After the favorable opinion of the Independent Ethics Committee, the PTV authorizes the HumetryMED observational study, coordinated by Prof. Massimo Andreoni at the Infectious Diseases Unit.PTV · resolution 697/2020, p. 11 ↗

2020–2021

The experience with Covid-19 patients

The trial explores remote monitoring in the ward and in the home phases. The clinical context guides the evolution of wearability and the solution.

21 APRIL 2021

The first medical generation

HUMETRYMED is published in the Italian database of medical devices: BD/RDM 2094536, Class I non-sterile and without measurement functions. A stage referring to that specific generation.

HUMETRY MED / NEW GENERATION

Designed around
contact with the person.

A compact form.
An essential interface.

Front view · design concept
Humetry MED back study with circular optical glass and contacts
Surface in contact with the skin · design study

The new generation project involves direct application to the skin. The flat back integrates the circular optical window and contacts; the front features the Humetry identity and the controls.

Illustrative representations of a configuration in development, not specific to a marketed device.

THE NEXT CHAPTER / HUMEDICAL

From the assets of FCI.
Towards the medical market.

HuMedical is the startup being established dedicated to the development and industrialization of the new Humetry MED generation.

The path includes device, platform and service, together with the validation and compliance activities necessary for future intended uses. The architecture also includes a home charging hub and the integration of a custom module on the arm for continuous glucose monitoring.

In 2026 the project was admitted to the START UP MOLISE benefits. The industrial phase continues with the required obligations and operational preparation.

New generation in development. The registration of the first generation in 2021 is a distinct historical milestone.

SCENARIOS FOR THE NEW GENERATION

Continuity of care.
Inside people's lives.

THE PERSON IN THEIR ENVIRONMENT

The journey continues, even at home.

We explore how to make longitudinal information available during home visits and after discharge, according to methods to be defined with healthcare organizations.

Scenario to be developed and validated with clinical partners.
THE ESSENTIAL ANSWERS

Understanding the path.

Can the new Humetry MED be purchased?

The new generation is in development. You can contact the team to find out about the path and collaboration opportunities.

What is the role of Formula Center Italia?

FCI is the company that developed the technology, testing and prototypes from which the project began. HuMedical is the corporate path dedicated to the subsequent medical phase.

How can a healthcare facility participate?

The discussion starts from clinical needs, context and requirements. Write to the team to discuss development and testing paths, without sending personal health data.

LET'S CONNECT IDEAS

The next chapter in care
is built together.

For healthcare organizations, technology and industry partners interested in medical development.

Talk to the team